BD 256084 Veritor SARS Kit + Analyzer ComboSARS-CoV-2

The BD 256084 Veritor SARS Kit + Analyzer Combo is a comprehensive diagnostic solution designed for clinics, hospitals, and laboratories. This innovative combo includes SARS-CoV-2 kits and an analyzer, providing a rapid and accurate means of detecting SARS-CoV-2 antibodies. With its standout benefit of quick results, this product is ideal for high-volume testing environments where timely diagnosis is crucial.

The BD 256084 Veritor SARS Kit + Analyzer Combo is intended for the qualitative detection of SARS-CoV-2 antibodies in human serum, plasma, or whole blood samples. This diagnostic system combines the simplicity of a point-of-care test with the accuracy of a laboratory-based assay, making it an excellent choice for a variety of healthcare settings. The analyzer is designed to work seamlessly with the SARS-CoV-2 kits, providing fast and reliable results that aid in the diagnosis and management of COVID-19.

Key Features

• Rapid results: Provides quick and accurate detection of SARS-CoV-2 antibodies
• Easy to use: Simple and intuitive design for point-of-care testing
• High sensitivity and specificity: Reliable results for confident diagnosis and patient management
• Compact design: Space-saving analyzer for convenient placement in clinics, hospitals, or laboratories
• Comprehensive kit: Includes everything needed for SARS-CoV-2 antibody detection, including sample preparation and analysis
• Accommodates various sample types: Compatible with serum, plasma, or whole blood samples for flexible testing options
• Supports high-volume testing: Designed for busy healthcare environments where rapid turnaround is essential

Product Specifications

• Dimensions: 7.5 inches (W) x 10.5 inches (D) x 12 inches (H) • Weight: Approximately 10 pounds • Materials: Durable plastic and metal construction for long-lasting performance • Compliance: Meets applicable regulatory requirements for in vitro diagnostic devices

Ideal For

• Hospitals and emergency departments • Clinics and outpatient facilities • Laboratories and research institutions • Public health organizations and screening programs • Home care and telehealth services (with appropriate training and supervision)